3049 POSTER Epoetin Alfa and Darbepoetin Alfa in Clinical Practice in Patients With Chemotherapy Induced Anemia in the Netherlands (EVALUATE)

2011 ◽  
Vol 47 ◽  
pp. S237
Author(s):  
C.J. van Groeningen ◽  
T.C. Kok ◽  
B. Biesma ◽  
C.F. Melissant ◽  
G. de Klerk ◽  
...  
Keyword(s):  
Clinical Practice ◽  
The Netherlands ◽  
Darbepoetin Alfa ◽  
Epoetin Alfa

Utilization and Cost in Clinical Practice of Darbepoetin Alfa and Epoetin Alfa for Anemia Concomitant With Chemotherapy

2012 ◽  
Vol 34 (6) ◽  
pp. 1350-1363 ◽  
Author(s):  
Ariel Berger ◽  
Claudia Lord ◽  
Patricia K. Corey-Lisle ◽  
G. Rhys Williams ◽  
Gerry Oster
Keyword(s):  
Clinical Practice ◽  
Darbepoetin Alfa ◽  
Epoetin Alfa

The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Paul C. D. Bank ◽  
Leo H. J. Jacobs ◽  
Sjoerd A. A. van den Berg ◽  
Hanneke W. M. van Deutekom ◽  
Dörte Hamann ◽  
...  
Keyword(s):  
Clinical Practice ◽  
The Netherlands ◽  
Medical Devices ◽  
Task Force ◽  
Large Impact ◽  
Guidance Document ◽  
Scientific Societies ◽  
Clinical Laboratories ◽  
The Impact

AbstractThe in vitro diagnostic medical devices regulation (IVDR) will take effect in May 2022. This regulation has a large impact on both the manufacturers of in vitro diagnostic medical devices (IVD) and clinical laboratories. For clinical laboratories, the IVDR poses restrictions on the use of laboratory developed tests (LDTs). To provide a uniform interpretation of the IVDR for colleagues in clinical practice, the IVDR Task Force was created by the scientific societies of laboratory specialties in the Netherlands. A guidance document with explanations and interpretations of relevant passages of the IVDR was drafted to help laboratories prepare for the impact of this new legislation. Feedback from interested parties and stakeholders was collected and used to further improve the document. Here we would like to present our approach to our European colleagues and inform them about the impact of the IVDR and, importantly we would like to present potentially useful approaches to fulfill the requirements of the IVDR for LDTs.

The effect of small peer group continuous quality improvement on the clinical practice of midwives in The Netherlands

Midwifery ◽  
2003 ◽  
Vol 19 (4) ◽  
pp. 250-258 ◽  
Author(s):  
Yvonne Engels ◽  
Nicole Verheijen ◽  
Margot Fleuren ◽  
Henk Mokkink ◽  
Richard Grol
Keyword(s):  
Quality Improvement ◽  
Clinical Practice ◽  
The Netherlands ◽  
Continuous Quality Improvement ◽  
Peer Group ◽  
Continuous Quality
Sign in / Sign up

Export Citation Format

Share Document